{"id":"ferric-sulfate","rwe":[{"pmid":"41620568","year":"2026","title":"Enhanced detoxification and valuable metal extraction from electroplating sludge via ultrasonic-assisted ferric sulfate bio acid.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41597036","year":"2025","title":"An Oxymetazoline-Based Hemostatic Solution Used with MTA for Pulpal Therapy: A Retrospective Study.","finding":"","journal":"Children (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41584115","year":"2026","title":"Synergistic effects of poly-silicon aluminum sulfate and auxiliary agents in dye wastewater decolorization.","finding":"","journal":"RSC advances","studyType":"Clinical Study"},{"pmid":"41500167","year":"2026","title":"High-performance polymeric aluminum ferric sulfate from Baihe pyrite slag: Enhanced coagulation in soil leaching alkaline wastewater and mechanistic insights.","finding":"","journal":"Journal of contaminant hydrology","studyType":"Clinical Study"},{"pmid":"41393478","year":"2025","title":"Success of pulpotomy with MTA in primary teeth: A systematic review and meta-analysis.","finding":"","journal":"Bioinformation","studyType":"Clinical Study"}],"tags":[{"label":"ferric sulfate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Dental","category":"route"},{"label":"Solution","category":"form"},{"label":"Active","category":"status"}],"phase":"discontinued","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["ferric persulfate","ferric sulfate"],"offLabel":[],"synonyms":["ferric persulfate","ferric sulfate"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"ferric sulfate","explanation":"Actions. Actions.","oneSentence":"Ferric sulfate works by binding to iron in the body, helping to treat conditions related to iron overload.","technicalDetail":"Ferric sulfate acts as an iron chelator, binding to iron ions and forming a stable complex that can be excreted from the body, thereby reducing iron levels and alleviating associated symptoms."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4529","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=FERRIC%20SULFATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FERRIC SULFATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:26:49.078266","biosimilars":[],"competitors":[],"genericName":"ferric sulfate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06884280","phase":"PHASE3","title":"Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study","status":"RECRUITING","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2025-11-13","conditions":["Peritoneal Dialysis","Anaemia","Iron Deficiency, Anaemia"],"enrollment":30,"completionDate":"2027-10"},{"nctId":"NCT07324928","phase":"NA","title":"Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth","status":"ENROLLING_BY_INVITATION","sponsor":"University of Jazan","startDate":"2026-03-07","conditions":["Pulptomy","Dental Caries","Pulp Therapy"],"enrollment":60,"completionDate":"2026-05-28"},{"nctId":"NCT07414199","phase":"PHASE4","title":"The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Orange County","startDate":"2026-01-31","conditions":["Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","Iron Deficiency Anaemia Due to Dietary Causes","Iron Deficiency Anemia Treatment","Iron Deficiency Anemia Secondary to IBD or Gastric Bypass","Iron Deficiency Anemias"],"enrollment":150,"completionDate":"2026-12-31"},{"nctId":"NCT07340450","phase":"NA","title":"Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-02-18","conditions":["Postpartum Anaemia"],"enrollment":122,"completionDate":"2025-08-18"},{"nctId":"NCT03817957","phase":"PHASE3","title":"Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency","status":"COMPLETED","sponsor":"Prof. Dr. Frank Behrens","startDate":"2018-09-18","conditions":["Iron Deficiency Anemia"],"enrollment":187,"completionDate":"2024-10-21"},{"nctId":"NCT05309499","phase":"NA","title":"An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function","status":"COMPLETED","sponsor":"Kazan State Medical University","startDate":"2021-12-05","conditions":["Myocardial Infarction","Iron-deficiency"],"enrollment":298,"completionDate":"2025-09-15"},{"nctId":"NCT07311291","phase":"NA","title":"The Effect of Different Hemostatic Agents on Hemorrhage Control, Pain and Quality of Life After Endodontic Microsurgery.","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2025-02-27","conditions":["Endodontic Infection","Periapical Diseases"],"enrollment":34,"completionDate":"2025-05-31"},{"nctId":"NCT04278651","phase":"PHASE4","title":"Early Antenatal Support for Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-09-29","conditions":["Pregnancy Related","Anemia, Iron Deficiency","Anemia of Pregnancy"],"enrollment":80,"completionDate":"2026-12-30"},{"nctId":"NCT05126901","phase":"PHASE3","title":"Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years","status":"COMPLETED","sponsor":"Shield Therapeutics","startDate":"2021-11-03","conditions":["Anemia","Iron-deficiency"],"enrollment":65,"completionDate":"2024-06-09"},{"nctId":"NCT04268849","phase":"PHASE3","title":"Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient","status":"RECRUITING","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2020-02-27","conditions":["Iron Deficiency Anemia"],"enrollment":104,"completionDate":"2026-02"},{"nctId":"NCT04253626","phase":"PHASE3","title":"Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-01-21","conditions":["Pregnancy Related","Anemia, Iron Deficiency"],"enrollment":83,"completionDate":"2024-07-01"},{"nctId":"NCT07122297","phase":"NA","title":"Evaluation of Gingival Displacement Methods","status":"COMPLETED","sponsor":"Zonguldak Bulent Ecevit University","startDate":"2015-12","conditions":["Gingival Displacement"],"enrollment":52,"completionDate":"2016-03"},{"nctId":"NCT07120321","phase":"NA","title":"Pulpotomy Materials in Primary Molars","status":"COMPLETED","sponsor":"Sacide Duman","startDate":"2022-01-01","conditions":["Dental Caries","Pulpitis"],"enrollment":22,"completionDate":"2025-07-01"},{"nctId":"NCT07053475","phase":"PHASE4","title":"IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches","status":"RECRUITING","sponsor":"Syed Hamza Mufarrih","startDate":"2025-04-02","conditions":["Heart Failure","Heart Failure With Reduced Ejection Fraction (HFrEF)","Heart Failure With Preserved Ejection Fraction (HFPEF)","Iron Deficiency","Iron-deficiency Anemia (IDA)"],"enrollment":250,"completionDate":"2027-03-31"},{"nctId":"NCT05462704","phase":"PHASE3","title":"Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-01-17","conditions":["Iron Deficiency Anemia","Pregnancy"],"enrollment":300,"completionDate":"2027-03-31"},{"nctId":"NCT03833336","phase":"PHASE3","title":"Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)","status":"COMPLETED","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2017-08-23","conditions":["Heart Failure With Normal Ejection Fraction","Ferropenic Anemia"],"enrollment":72,"completionDate":"2024-12-20"},{"nctId":"NCT05642689","phase":"NA","title":"Evaluation of Fe Absorption From Iron Salt in Milk","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2009-11","conditions":["Healthy"],"enrollment":40,"completionDate":"2010-03"},{"nctId":"NCT00236964","phase":"PHASE3","title":"Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-02-23","conditions":["Anemia"],"enrollment":96,"completionDate":"2002-05-30"},{"nctId":"NCT05545527","phase":"","title":"Neuroimaging Ancillary Study","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2023-02-21","conditions":["Iron Deficiency Anemia","Iron Deficiency Anemia of Pregnancy","Neurodevelopmental Disorder of Foetus","Iron Deficiency Anemia Treatment","Fetal Neurodevelopmental Disorder","Child Development"],"enrollment":184,"completionDate":"2025-04-07"},{"nctId":"NCT05060731","phase":"PHASE4","title":"Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"University of Pecs","startDate":"2025-09-01","conditions":["GastroIntestinal Bleeding","Anemia"],"enrollment":570,"completionDate":"2028-02-01"},{"nctId":"NCT05557812","phase":"EARLY_PHASE1","title":"A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2023-02-02","conditions":["Pulpitis"],"enrollment":19,"completionDate":"2025-02-01"},{"nctId":"NCT05304442","phase":"PHASE3","title":"IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-09-15","conditions":["Anemia, Iron Deficiency","Uterine Bleeding"],"enrollment":40,"completionDate":"2025-04"},{"nctId":"NCT04087993","phase":"PHASE3","title":"Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients","status":"WITHDRAWN","sponsor":"Dr. Frank Behrens","startDate":"2020-05-15","conditions":["Iron Deficiency Anemia"],"enrollment":0,"completionDate":"2020-12-31"},{"nctId":"NCT05358509","phase":"PHASE4","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-03-15","conditions":["Iron Deficiency Anemia","Infant, Low Birth Weight","Anemia of Pregnancy"],"enrollment":4368,"completionDate":"2024-01-21"},{"nctId":"NCT06403306","phase":"NA","title":"Evaluation of Pulpotomy Success of Different Methods","status":"COMPLETED","sponsor":"Tokat Gaziosmanpasa University","startDate":"2018-04-01","conditions":["Pulpal Bleeding; Staining","Primary Teeth","Pulpotomy"],"enrollment":81,"completionDate":"2019-10-01"},{"nctId":"NCT06366698","phase":"PHASE3","title":"Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-11-21","conditions":["Iron Deficiency Anemia of Pregnancy"],"enrollment":900,"completionDate":"2025-12-30"},{"nctId":"NCT03457701","phase":"PHASE2","title":"Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-07-30","conditions":["Anaemia"],"enrollment":15,"completionDate":"2022-07-05"},{"nctId":"NCT05226169","phase":"PHASE3","title":"Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2022-04-29","conditions":["Advanced Gastric Carcinoma"],"enrollment":330,"completionDate":"2024-11-30"},{"nctId":"NCT05504863","phase":"","title":"RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2022-10-11","conditions":["Iron Deficiency Anemia","Neurodevelopmental Abnormality","Autism Spectrum Disorder"],"enrollment":538,"completionDate":"2026-01"},{"nctId":"NCT04205266","phase":"PHASE4","title":"IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2020-02-14","conditions":["Anemia, Iron Deficiency","Heavy Menstrual Bleeding"],"enrollment":76,"completionDate":"2025-01"},{"nctId":"NCT04976179","phase":"PHASE3","title":"Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2021-08-09","conditions":["Iron Deficiency Anemia of Pregnancy"],"enrollment":1056,"completionDate":"2023-06-15"},{"nctId":"NCT04608539","phase":"PHASE4","title":"A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery","status":"COMPLETED","sponsor":"Michael Kremke","startDate":"2021-05-21","conditions":["Anemia Postoperative"],"enrollment":110,"completionDate":"2023-06-27"},{"nctId":"NCT05792748","phase":"NA","title":"Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth","status":"COMPLETED","sponsor":"King Abdullah University Hospital","startDate":"2013-01-02","conditions":["Pulpotomy"],"enrollment":65,"completionDate":"2014-04-01"},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":["Iron Deficiency Anemia"],"enrollment":100,"completionDate":"2027-01"},{"nctId":"NCT03657433","phase":"PHASE3","title":"Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2018-12-17","conditions":["Iron Deficiency Anemia of Pregnancy"],"enrollment":124,"completionDate":"2022-04-01"},{"nctId":"NCT03957057","phase":"PHASE3","title":"Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-10","conditions":["Postpartum Anemia Nos","Iron-deficiency"],"enrollment":300,"completionDate":"2022-06-15"},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":["Iron Deficiency Anemia"],"enrollment":79,"completionDate":"2021-01-29"},{"nctId":"NCT03660462","phase":"NA","title":"Iron Bioavailability of High Surface Area Ferric Phosphate","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2018-11-21","conditions":["Iron-deficiency"],"enrollment":18,"completionDate":"2019-07-19"},{"nctId":"NCT04115358","phase":"NA","title":"Evaluation of Hyaluronic Acid Pulpotomies in Primary Molars","status":"COMPLETED","sponsor":"Marmara University","startDate":"2019-05-01","conditions":["Pulpitis"],"enrollment":47,"completionDate":"2020-10-01"},{"nctId":"NCT03972683","phase":"EARLY_PHASE1","title":"Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training","status":"WITHDRAWN","sponsor":"Colorado State University","startDate":"2019-04-16","conditions":["Vasoconstriction","Vasodilation"],"enrollment":0,"completionDate":"2021-07-31"},{"nctId":"NCT00223938","phase":"PHASE4","title":"Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.","status":"TERMINATED","sponsor":"Sanofi","startDate":"2003-12-30","conditions":["Anemia"],"enrollment":112,"completionDate":"2007-04-27"},{"nctId":"NCT02783911","phase":"NA","title":"Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2015-01-29","conditions":["Primary Teeth","Pulpotomy"],"enrollment":57,"completionDate":"2017-03-14"},{"nctId":"NCT04915196","phase":"","title":"Tolerability of Iron Therapy in Women With AUB","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2021-07-01","conditions":["Iron Deficiency Anemia","Abnormal Uterine Bleeding"],"enrollment":20,"completionDate":"2022-07-01"},{"nctId":"NCT02469480","phase":"PHASE2","title":"Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2015-03","conditions":["Metastatic Colorectal Cancer"],"enrollment":64,"completionDate":"2020-08"},{"nctId":"NCT00236977","phase":"PHASE3","title":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-08","conditions":["Anemia"],"enrollment":182,"completionDate":"2004-10"},{"nctId":"NCT02905981","phase":"PHASE2","title":"Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol","status":"TERMINATED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2017-01-17","conditions":["Iron-Refractory Iron-Deficiency Anemia"],"enrollment":1,"completionDate":"2018-03-15"},{"nctId":"NCT02086968","phase":"PHASE4","title":"Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2014-01-01","conditions":["Iron Deficiency Anemia Secondary to IBD or Gastric Bypass"],"enrollment":198,"completionDate":"2017-10"},{"nctId":"NCT02888171","phase":"NA","title":"Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2016-09","conditions":["Chronic Kidney Disease","Iron Deficiency","Anemia"],"enrollment":60,"completionDate":"2019-03-30"},{"nctId":"NCT03777514","phase":"NA","title":"Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2019-08","conditions":["IDA in the Post-bariatric Surgical Patient"],"enrollment":0,"completionDate":"2022-09"},{"nctId":"NCT03762148","phase":"NA","title":"Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C","status":"COMPLETED","sponsor":"Isabelle Herter-Aeberli","startDate":"2019-04-01","conditions":["Iron-deficiency"],"enrollment":46,"completionDate":"2019-06-11"},{"nctId":"NCT03718676","phase":"NA","title":"Pulpotomy With Various MTA Materials and Ferric Sulphate","status":"COMPLETED","sponsor":"Aydin Adnan Menderes University","startDate":"2017-06-02","conditions":["Pulpotomy"],"enrollment":32,"completionDate":"2018-12-30"},{"nctId":"NCT02767128","phase":"PHASE1","title":"Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2016-04","conditions":["Iron-refractory, Iron-deficiency Anemia (IRIDA)"],"enrollment":14,"completionDate":"2016-04"},{"nctId":"NCT02496377","phase":"NA","title":"Cross Iron (Comparative Randomized Oral Versus Systemic IRON)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2014-08-29","conditions":["Allogenic Transfusion","Perioperative Anaemia","Knee Arthroplasty","Hip Arthroplasty"],"enrollment":100,"completionDate":"2016-10-16"},{"nctId":"NCT03703739","phase":"NA","title":"Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents","status":"UNKNOWN","sponsor":"Swiss Federal Institute of Technology","startDate":"2018-10-02","conditions":["Iron-deficiency"],"enrollment":22,"completionDate":"2018-12"},{"nctId":"NCT03586245","phase":"NA","title":"Iron Absorption From Iron Enriched Aspergillus Oryzae in Females Using Stable Isotope Methodology","status":"COMPLETED","sponsor":"Iowa State University","startDate":"2016-10-28","conditions":["Iron Absorption"],"enrollment":35,"completionDate":"2017-06-20"},{"nctId":"NCT00982007","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2009-09","conditions":["Iron Deficiency Anemia"],"enrollment":997,"completionDate":"2011-08"},{"nctId":"NCT00704353","phase":"PHASE3","title":"Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2008-06","conditions":["Anemia"],"enrollment":735,"completionDate":"2011-03"},{"nctId":"NCT00354484","phase":"PHASE3","title":"Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-05","conditions":["Postpartum Anemia"],"enrollment":291,"completionDate":"2007-01"},{"nctId":"NCT00395993","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-05","conditions":["Anemia"],"enrollment":456,"completionDate":"2006-06"},{"nctId":"NCT00317239","phase":"PHASE3","title":"VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-05","conditions":["Anemia"],"enrollment":255,"completionDate":"2007-08"},{"nctId":"NCT00396292","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-02","conditions":["Anemia"],"enrollment":361,"completionDate":"2006-02"},{"nctId":"NCT03135626","phase":"PHASE3","title":"Comparison of The Success Rates of Four Different Pulpotomy Techniques","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2013-03-15","conditions":["Extensive Decay in Primary Molars"],"enrollment":38,"completionDate":"2016-02-15"},{"nctId":"NCT02541708","phase":"PHASE3","title":"IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania","status":"UNKNOWN","sponsor":"Ifakara Health Institute","startDate":"2015-09","conditions":["Iron-Deficiency Anemia"],"enrollment":230,"completionDate":"2018-04"},{"nctId":"NCT02714075","phase":"NA","title":"Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Zinc, Citric Acid/Trisodium Citrate and EDTA","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2016-04","conditions":["Iron Deficiency and/or Anemia"],"enrollment":30,"completionDate":"2016-06"},{"nctId":"NCT01701310","phase":"PHASE4","title":"IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia","status":"COMPLETED","sponsor":"Nottingham University Hospitals NHS Trust","startDate":"2012-04","conditions":["Anemia","Colorectal Neoplasm"],"enrollment":116,"completionDate":"2014-12"},{"nctId":"NCT00830037","phase":"PHASE4","title":"A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease","status":"TERMINATED","sponsor":"Indiana University","startDate":"2008-08","conditions":["Chronic Kidney Disease","Iron-deficiency Anemia"],"enrollment":136,"completionDate":""},{"nctId":"NCT02572128","phase":"NA","title":"Mineral Absorption From Fortified Rice Produced With Different Fortification Techniques","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2015-06","conditions":["Iron Deficiency"],"enrollment":44,"completionDate":"2015-12"},{"nctId":"NCT02255942","phase":"NA","title":"The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2015-04","conditions":["Iron Deficiency"],"enrollment":20,"completionDate":"2015-07"},{"nctId":"NCT01913808","phase":"PHASE4","title":"Comparing Intravenous and Oral Iron in Postoperative Anemia","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2011-01","conditions":["Postoperative Anemia","Osteoarthritis, Knee"],"enrollment":122,"completionDate":"2013-01"},{"nctId":"NCT02019563","phase":"PHASE2","title":"MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2010-09","conditions":["Dental Caries","Dental Pulp Exposure"],"enrollment":70,"completionDate":"2014-09"},{"nctId":"NCT01131624","phase":"PHASE3","title":"Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2010-05","conditions":["Anaemia"],"enrollment":252,"completionDate":"2015-04"},{"nctId":"NCT01067547","phase":"PHASE4","title":"A Trial of Iron Replacement in Patients With Iron Deficiency.","status":"COMPLETED","sponsor":"Richard Fedorak","startDate":"2010-03","conditions":["Iron Deficiency","Inflammatory Bowel Disease"],"enrollment":130,"completionDate":"2014-05"},{"nctId":"NCT02176759","phase":"NA","title":"Iron Absorption From Rice Fortified With Ferric Pyrophosphate","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2014-09","conditions":["Iron Deficiency","Anemia","Iron Deficiency Anemia"],"enrollment":20,"completionDate":""},{"nctId":"NCT00994318","phase":"PHASE3","title":"Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2009-12","conditions":["Iron Deficiency Anaemia","Chronic Kidney Disease"],"enrollment":626,"completionDate":"2014-02"},{"nctId":"NCT02128971","phase":"PHASE2","title":"A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo","status":"UNKNOWN","sponsor":"Albion","startDate":"2014-04","conditions":["Anemia"],"enrollment":108,"completionDate":"2014-08"},{"nctId":"NCT01991600","phase":"EARLY_PHASE1","title":"A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2006-05","conditions":["Iron Deficiency Anaemia"],"enrollment":71,"completionDate":"2010-05"},{"nctId":"NCT00867867","phase":"PHASE1","title":"Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2003-10","conditions":["Healthy Participants","Non-anemic Children","Helicobacter Pylori Infection"],"enrollment":235,"completionDate":"2008-06"},{"nctId":"NCT00223977","phase":"PHASE2,PHASE3","title":"2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-12","conditions":["Iron Deficiency Anemia"],"enrollment":146,"completionDate":"2008-02"},{"nctId":"NCT00224055","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":["Anemia, Iron-Deficiency","Kidney Failure, Chronic"],"enrollment":89,"completionDate":"2004-09"},{"nctId":"NCT00224042","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":["Anemia, Iron-Deficiency","Kidney Failure, Chronic"],"enrollment":52,"completionDate":""},{"nctId":"NCT00224068","phase":"PHASE4","title":"Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2002-05","conditions":["Anemia"],"enrollment":180,"completionDate":"2003-12"},{"nctId":"NCT00929409","phase":"PHASE2,PHASE3","title":"Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia","status":"TERMINATED","sponsor":"Norwegian University of Science and Technology","startDate":"2009-06","conditions":["Anemia, Iron-Deficiency","Puerperal Disorders","Depression, Postpartum"],"enrollment":30,"completionDate":"2010-07"},{"nctId":"NCT00661999","phase":"PHASE3","title":"Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-01","conditions":["Anemia","Leukemia","Lymphoma","Lymphoproliferative Disorder","Multiple Myeloma and Plasma Cell Neoplasm","Precancerous Condition","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":502,"completionDate":"2009-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Dental","formulation":"Solution","formulations":[{"form":"SOLUTION","route":"DENTAL","productName":"STASIS"}]},"crossReferences":{"NUI":"N0000147365","NDDF":"006096","UNII":"3HWS7HF5XD","VUID":"4019109","CHEBI":"CHEBI:53438","VANDF":"4019109","RXNORM":"24913","UMLSCUI":"C0060246","ChEMBL_ID":"CHEMBL5095046","KEGG_DRUG":"D08922","DRUGBANK_ID":"DB11171","PUBCHEM_CID":"24826","SECONDARY_CAS_RN":"142906-29-4","MESH_SUPPLEMENTAL_RECORD_UI":"C024823"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":419,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 31","pmid":"41620568","title":"Enhanced detoxification and valuable metal extraction from electroplating sludge via ultrasonic-assisted ferric sulfate bio acid.","journal":"Scientific reports"},{"date":"2025 Dec 24","pmid":"41597036","title":"An Oxymetazoline-Based Hemostatic Solution Used with MTA for Pulpal Therapy: A Retrospective Study.","journal":"Children (Basel, Switzerland)"},{"date":"2026 Jan 21","pmid":"41584115","title":"Synergistic effects of poly-silicon aluminum sulfate and auxiliary agents in dye wastewater decolorization.","journal":"RSC advances"},{"date":"2026 Feb","pmid":"41500167","title":"High-performance polymeric aluminum ferric sulfate from Baihe pyrite slag: Enhanced coagulation in soil leaching alkaline wastewater and mechanistic insights.","journal":"Journal of contaminant hydrology"},{"date":"2025","pmid":"41393478","title":"Success of pulpotomy with MTA in primary teeth: A systematic review and meta-analysis.","journal":"Bioinformation"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"discontinued","brandName":"FERRIC SULFATE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ferric sulfate is a small molecule drug in the ferric sulfate class, but its original developer and current owner are unknown. Its target and approved indications are also not specified. The commercial status of ferric sulfate is unclear, and it is unknown whether it is patented or available as a generic medication. Ferric sulfate's pharmacokinetic properties, including half-life and bioavailability, are also unknown. Further research is needed to determine the safety and efficacy of ferric sulfate.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}